SNORA72调控RPL5/11核内移位介导OCSCs核糖体应激的分子机制

国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
卵巢癌干细胞(OCSCs)是卵巢癌复发和耐药的根源。核糖体合成与应激平衡是干性维持的关键环节,RPL5/11是介导核糖体合成与应激平衡的关键因子。SNORNAs作为介导细胞核异质性的核心因子,是否介导核糖体合成与应激平衡影响OCSCs特性?课题组发现:SNORA72过表达升高核仁中RPL5/11表达、降低核质中表达;SNORA72诱导OCSCs核糖体合成增加的同时,应激途径减弱;同步检测到SNORA72与OCSCs密切相关的HIF-2α表达正相关。本项目拟在确认RPL5/11核内移位是OCSCs中SNORA72调控核糖体合成与应激平衡的关键环节基础上,明确SNORA72调控OCSCs干性的机制;确认HIF-2α与SNORA72关键HRE元件,阐明HIF-2α转录激活SNORA72进而调节OSCSs的核糖体合成与应激平衡的分子机制。本研究为揭示OCSCs干性形成新机制与新靶点提供依据。
英文摘要
Ovarian cancer stem cells (OCSCs) are responsible for the recurrence and chemoresistance of ovarian cancer. The balance between ribosomal synthesis process and ribosomal stress plays a key role in maintaining stemness of cancer cells, and RPL5/11 are key factors in mediating the balance between ribosomal synthesis process and ribosomal stress. Do SNORNAs, as core factors mediating nuclear heterogeneity, mediate the balance between ribosomal synthesis process and ribosomal stress and then affect the characteristics of OCSCs? What are the possible regulatory mechanisms? We found that the overexpression of SNORA72 increased RPL5/11 expression in nucleoli and decreased the expression of those in the nucleoplasm, and SNORA72 increased ribosomal synthesis process and depressed the ribosomal stress in OCSCs. HIF-2α, which is closely related to OCSCs, was detected simultaneously and was positively correlated with the expression of SNORA72. This project is to confirm the mechanism of regulating RPL5/11-MDM2-P53 ribosomal stress based on the identification of SNORA72 recruitment of RPL5/11 nucleolar translocation as a key step, and confirm the key HRE elements of HIF-2α binding to the host gene of SNORA72, and then clarify the molecular mechanism that SNORA72 is activated by HIF-2α, and then regulates the stemness of OCSCs by inhibiting ribosomal stress. This project will provide a new idea and target for deep researching the mechanism of maintaining the OCSCs characteristics.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1186/s12575-021-00161-9
发表时间:2021-12-15
期刊:Biological procedures online
影响因子:6.4
作者:Sun X;Li S;Lv X;Yan Y;Wei M;He M;Wang X
通讯作者:Wang X
DOI:10.2174/0929867329666220829095334
发表时间:2022
期刊:Current Medicinal Chemistry
影响因子:--
作者:Hongyuan Lu;Miao He;Minjie Wei;Yan Zhu;Wenwu Liu;Yuanyuan Yan;Xiaowen Jiang;Qinbiao Wang;Yanyun Zhao
通讯作者:Yanyun Zhao
DOI:10.1186/s12885-023-11015-w
发表时间:2023-06-09
期刊:BMC CANCER
影响因子:3.8
作者:Li, Huanyu;Sun, Xiaoyu;Zhao, Yanyun;Zhang, Changzhu;Jiang, Kai;Ren, Jie;Xing, Lijuan;He, Miao
通讯作者:He, Miao
A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPR(ER) axis.
一种新型 HIF-2α 靶向抑制剂通过 SOD2-mtROS-PDI/GPR78-UPRER 轴抑制缺氧诱导的乳腺癌干性
DOI:10.1038/s41418-022-00963-8
发表时间:2022-09
期刊:CELL DEATH AND DIFFERENTIATION
影响因子:12.4
作者:Yan, Yuanyuan;He, Miao;Zhao, Lin;Wu, Huizhe;Zhao, Yanyun;Han, Li;Wei, Binbin;Ye, Dongman;Lv, Xuemei;Wang, Yan;Yao, Weifan;Zhao, Haishan;Chen, Bo;Jin, Zining;Wen, Jian;Zhu, Yan;Yu, Tao;Jin, Feng;Wei, Minjie
通讯作者:Wei, Minjie
DOI:10.1016/j.bbcan.2023.188996
发表时间:2023
期刊:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
影响因子:--
作者:Manxi Ge;Yan Zhu;Minjie Wei;Haozhe Piao;Miao He
通讯作者:Miao He
HOTTIP作为ceRNA调控WNT1/TCF4介导的乳腺癌干细胞特性的分子机制
- 批准号:81572898
- 项目类别:面上项目
- 资助金额:57.0万元
- 批准年份:2015
- 负责人:何苗
- 依托单位:
miR-487a调控乳腺癌耐药蛋白表达与功能的靶向作用及分子机制
- 批准号:81102472
- 项目类别:青年科学基金项目
- 资助金额:23.0万元
- 批准年份:2011
- 负责人:何苗
- 依托单位:
国内基金
海外基金
